FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996996863> ?p ?o ?g. }

• W1996996863 endingPage "1045" @default.
• W1996996863 startingPage "1033" @default.
• W1996996863 abstract "Purpose: This study aimed to evaluate the effects of endostatin on tight junction (TJ) integrity in retinal microvascular endothelial cells (RMECs) in vitro and in vivo. Moreover, it was hypothesized that endostatin-induced occludin upregulation regulated VEGF165-mediated increases in endothelial cell permeability and involved activation of the MAPK signaling cascade. Endostatin is a 20-kDa fragment of collagen XVIII that has been shown to be efficacious in the eye by preventing retinal neovascularization. Endostatin is a specific inhibitor of endothelial cell proliferation, migration, and angiogenesis and has been reported to reverse VEGF-mediated increases in vasopermeability and to promote integrity of the blood-retinal barrier (BRB). In order to determine the mechanism of endostatin action on BRB integrity, we have examined the effects of endostatin on a number of intracellular pathways implicated in endothelial cell physiology. Methods: C57/Bl6 mice were injected with VEGF165 and/or endostatin, and the distribution of occludin staining was determined using retinal flatmounts. Western blot analysis of RMECs treated with VEGF165 and/or endostatin was used to determine changes in occludin expression and p38 MAPK and extracellular regulated kinase (ERK1/ERK2 MAPK) activation, while FD-4 flux across the RMEC monolayer was used to determine changes in paracellular permeability. Results: Endostatin prevented the discontinuous pattern of occludin staining observed at the retinal blood vessels of mice administered an intraocular injection of VEGF165. It was shown that endostatin activated p38 MAPK 5 min after addition to RMECs and continued to do so for approximately 30 min. Endostatin was also shown to activate ERK1/ERK2 5 min after addition and continued to do so, albeit with less potency, up to and including 15 min after addition. Inhibition of p38 MAPK and ERK1/ERK2 prevented endostatin's ability to upregulate levels of occludin expression. Inhibition of these key signaling molecules was shown to prevent endostatin's ability to protect against VEGF165-mediated increases in paracellular permeability in vitro. However, it appears that p38 MAPK may play a more important role in VEGF-mediated permeability, as inhibition of ERK1/ERK2 will not prevent VEGF165-mediated permeability compared with control (untreated) cells or cells treated with both a p38 MAPK inhibitor and VEGF165. Conclusions: Occludin is important for the maintenance of tight junction integrity in vivo. In a p38 MAPK and ERK1/ERK2 dependent manner, endostatin was shown to upregulate the levels of expression of the tight junction protein occludin. Inhibition of these key MAPK components may prevent endostatin's ability to decrease VEGF165-induced paracellular permeability." @default.
• W1996996863 created "2016-06-24" @default.
• W1996996863 creator A5005529128 @default.
• W1996996863 creator A5009631835 @default.
• W1996996863 creator A5025321891 @default.
• W1996996863 creator A5034070107 @default.
• W1996996863 creator A5048181374 @default.
• W1996996863 creator A5070300226 @default.
• W1996996863 date "2006-01-01" @default.
• W1996996863 modified "2023-10-18" @default.
• W1996996863 title "Involvement of MAPKs in Endostatin-Mediated Regulation of Blood-Retinal Barrier Function" @default.
• W1996996863 cites W1568605582 @default.
• W1996996863 cites W1573711140 @default.
• W1996996863 cites W1590981745 @default.
• W1996996863 cites W1989067276 @default.
• W1996996863 cites W1990301804 @default.
• W1996996863 cites W2015684586 @default.
• W1996996863 cites W2030570835 @default.
• W1996996863 cites W2034046160 @default.
• W1996996863 cites W2039200600 @default.
• W1996996863 cites W2058198695 @default.
• W1996996863 cites W2072483904 @default.
• W1996996863 cites W2078868629 @default.
• W1996996863 cites W2086037348 @default.
• W1996996863 cites W2087899702 @default.
• W1996996863 cites W2088488718 @default.
• W1996996863 cites W2092374816 @default.
• W1996996863 cites W2106597930 @default.
• W1996996863 cites W2124974853 @default.
• W1996996863 cites W2131798870 @default.
• W1996996863 cites W2142638534 @default.
• W1996996863 cites W2146804301 @default.
• W1996996863 cites W2147453419 @default.
• W1996996863 cites W2147527625 @default.
• W1996996863 cites W2148413520 @default.
• W1996996863 cites W2170723552 @default.
• W1996996863 cites W4245029649 @default.
• W1996996863 cites W56534538 @default.
• W1996996863 doi "https://doi.org/10.1080/02713680601013025" @default.
• W1996996863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17169842" @default.
• W1996996863 hasPublicationYear "2006" @default.
• W1996996863 type Work @default.
• W1996996863 sameAs 1996996863 @default.
• W1996996863 citedByCount "31" @default.
• W1996996863 countsByYear W19969968632012 @default.
• W1996996863 countsByYear W19969968632013 @default.
• W1996996863 countsByYear W19969968632014 @default.
• W1996996863 countsByYear W19969968632016 @default.
• W1996996863 countsByYear W19969968632017 @default.
• W1996996863 countsByYear W19969968632019 @default.
• W1996996863 countsByYear W19969968632020 @default.
• W1996996863 countsByYear W19969968632021 @default.
• W1996996863 crossrefType "journal-article" @default.
• W1996996863 hasAuthorship W1996996863A5005529128 @default.
• W1996996863 hasAuthorship W1996996863A5009631835 @default.
• W1996996863 hasAuthorship W1996996863A5025321891 @default.
• W1996996863 hasAuthorship W1996996863A5034070107 @default.
• W1996996863 hasAuthorship W1996996863A5048181374 @default.
• W1996996863 hasAuthorship W1996996863A5070300226 @default.
• W1996996863 hasConcept C123012128 @default.
• W1996996863 hasConcept C134018914 @default.
• W1996996863 hasConcept C177779419 @default.
• W1996996863 hasConcept C185592680 @default.
• W1996996863 hasConcept C202751555 @default.
• W1996996863 hasConcept C2775962179 @default.
• W1996996863 hasConcept C2778371105 @default.
• W1996996863 hasConcept C2779829184 @default.
• W1996996863 hasConcept C2780394083 @default.
• W1996996863 hasConcept C2780827179 @default.
• W1996996863 hasConcept C502942594 @default.
• W1996996863 hasConcept C51551487 @default.
• W1996996863 hasConcept C55493867 @default.
• W1996996863 hasConcept C555293320 @default.
• W1996996863 hasConcept C57074206 @default.
• W1996996863 hasConcept C62478195 @default.
• W1996996863 hasConcept C75920679 @default.
• W1996996863 hasConcept C86803240 @default.
• W1996996863 hasConcept C95444343 @default.
• W1996996863 hasConceptScore W1996996863C123012128 @default.
• W1996996863 hasConceptScore W1996996863C134018914 @default.
• W1996996863 hasConceptScore W1996996863C177779419 @default.
• W1996996863 hasConceptScore W1996996863C185592680 @default.
• W1996996863 hasConceptScore W1996996863C202751555 @default.
• W1996996863 hasConceptScore W1996996863C2775962179 @default.
• W1996996863 hasConceptScore W1996996863C2778371105 @default.
• W1996996863 hasConceptScore W1996996863C2779829184 @default.
• W1996996863 hasConceptScore W1996996863C2780394083 @default.
• W1996996863 hasConceptScore W1996996863C2780827179 @default.
• W1996996863 hasConceptScore W1996996863C502942594 @default.
• W1996996863 hasConceptScore W1996996863C51551487 @default.
• W1996996863 hasConceptScore W1996996863C55493867 @default.
• W1996996863 hasConceptScore W1996996863C555293320 @default.
• W1996996863 hasConceptScore W1996996863C57074206 @default.
• W1996996863 hasConceptScore W1996996863C62478195 @default.
• W1996996863 hasConceptScore W1996996863C75920679 @default.
• W1996996863 hasConceptScore W1996996863C86803240 @default.
• W1996996863 hasConceptScore W1996996863C95444343 @default.
• W1996996863 hasIssue "12" @default.

• next